Penbutolol is a non-selective beta-blocker primarily indicated for the management of hypertension and the treatment of angina pectoris. As a beta-adrenergic receptor antagonist, it functions by reducing… Read more







Penbutolol is a non-selective beta-blocker primarily indicated for the management of hypertension and the treatment of angina pectoris. As a beta-adrenergic receptor antagonist, it functions by reducing the heart rate and force of contraction. This category provides essential materials for pharmaceutical research and development, including racemic and enantiomeric reference standards, degradation products, and specific metabolites such as 4-hydroxy penbutolol. These high-quality reference standards are critical for rigorous impurity profiling, method validation, and routine quality control testing in manufacturing environments. Furthermore, stable isotope labelled compounds, including various deuterated penbutolol derivatives, act as indispensable internal standards in liquid chromatography-mass spectrometry to support precise quantification in pharmacokinetic studies and bioanalytical assays. Laboratories rely on these comprehensive materials to ensure regulatory compliance and the consistent safety and efficacy of the final pharmaceutical product.